Organo Corporation
Stock Price Chart
2026/10/02 11:38 UpdatedPrice Trend
2026/10/02 11:38 UpdatedPrice & Trading Details
2026/10/02 11:38 UpdatedPRICE
TRADING
Analyst Recommendations 2 analysts
Updated 2026/10/01Earnings Calendar
Updated 2026/10/01Recent Earnings
| Date | EPS Est. | EPS Actual | Surprise |
|---|---|---|---|
| 2026/08/03 | ¥26.84 | ¥14.95 | -44.3% |
| 2026/05/12 | ¥39.61 | ¥45.25 | +14.2% |
| 2026/02/03 | ¥33.41 | ¥28.15 | -15.8% |
| 2025/10/30 | ¥25.94 | ¥34.31 | +32.3% |
Shareholder Composition
Updated 2026/10/01Top Mutual Funds / ETFs
Updated 2026/10/01Major Holders
Updated 2026/10/01| Fund Name | Ownership | Shares | Change |
|---|---|---|---|
|
Perpetual Americas Funds Trust-JOHCM International Select Fund
|
2.2M | -18.23% | |
|
VANGUARD STAR FUNDS-Vanguard Total International Stock Index Fund
|
1.8M | +0.61% | |
|
LAZARD FUNDS INC-Lazard International Strategic Equity Portfolio
|
1.3M | +33.27% | |
|
VANGUARD TAX-MANAGED FUNDS-Vanguard Developed Markets Index Fund
|
1.3M | +3.55% | |
|
iShares Trust-iShares Core MSCI EAFE ETF
|
954.5K | 0.00% | |
|
TRANSAMERICA FUNDS-Transamerica International Small Cap Value
|
603.5K | 0.00% |
Dividend History
Updated 2026/09/27| Year | Dividend | Change |
|---|---|---|
| 2026 | ¥105 | -42.9% |
| 2025 | ¥184 | +39.4% |
| 2024 | ¥132 | +78.4% |
| 2023 | ¥74 | +45.1% |
| 2022 | ¥51 | - |
Financial Performance
2026/09/27 UpdatedRevenue & Profit
Margins
Cash Flow
Financial Health
| 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|
| Income Statement | ||||
| Revenue | ¥112,069M | ¥132,426M | ¥150,356M | ¥163,269M |
| Gross Profit | ¥28,512M | ¥34,976M | ¥43,841M | ¥55,182M |
| Operating Income | ¥10,850M | ¥15,213M | ¥22,544M | ¥31,121M |
| Pretax Income | ¥12,823M | ¥16,194M | ¥23,873M | ¥32,604M |
| Net Income | ¥9,210M | ¥11,730M | ¥17,310M | ¥24,150M |
| EPS | ¥200.67 | ¥255.77 | ¥376.92 | ¥525.37 |
| Operating Margin | 9.68% | 11.49% | 14.99% | 19.06% |
| Balance Sheet | ||||
| Total Assets | ¥130,506M | ¥164,854M | ¥182,703M | ¥194,396M |
| Total Equity | ¥75,836M | ¥86,169M | ¥101,927M | ¥120,947M |
| Total Liabilities | ¥54,670M | ¥78,685M | ¥80,776M | ¥73,449M |
| Cash | ¥20,198M | ¥15,558M | ¥17,642M | ¥16,751M |
| Interest-bearing Debt | ¥15,628M | ¥33,019M | ¥36,465M | ¥22,557M |
| Equity Ratio | 58.11% | 52.27% | 55.79% | 62.22% |
| D/E Ratio | 0.21 | 0.38 | 0.36 | 0.19 |
| Cash Flow | ||||
| Operating CF | ¥10,787M | -¥18,536M | ¥3,726M | ¥21,100M |
| Investing CF | -¥1,520M | -¥1,309M | -¥1,415M | -¥2,130M |
| Financing CF | -¥2,586M | ¥14,706M | -¥641M | -¥20,821M |
| Free CF | ¥7,989M | -¥19,988M | ¥2,079M | ¥18,411M |
| Efficiency | ||||
| ROE | 12.14% | 13.61% | 16.98% | 19.97% |
| ROA | 7.06% | 7.12% | 9.47% | 12.42% |
Latest IR Information
-
Organo Corporation (6386) FY2027 Q1 Financial Summary
Disclosure of FY2027 Q1 results. Revenues, operating income, ordinary income, net income, and per-share information are presented in sections. Segment breakdowns and capital policy-related disclosures are provided in separate sections. YoY and QoQ comparisons may be included.
Read more -
Fiscal Year 2027 First Quarter Supplementary Financial Information
Presents the consolidated results for the first quarter of Fiscal Year 2027. Orders were 167,956 million yen, net sales were 177,654 million yen, and operating income was 37,648 million yen, with comparisons to the previous period and full-year outlook. Breakdowns...
Read more
Latest News (5 items)
-
Average Analyst Rating: strong_buy
Average Target Price: ¥3,960
Rating Score: 1.00 (Based on 2 analysts)
※1=Strong Buy, 5=Strong Sell
Company Information
About
Organo Corporation operates as a water treatment engineering company in Japan, Taiwan, the United States, China, Southeast Asia, and internationally. The company engages in the manufacturing, sales, and maintenance of various water and wastewater treatment systems utilizing ion exchange resins, separation membranes, activated carbon, etc.; provision of water treatment outsourcing services; and sales of various water treatment chemicals and food processing materials. Its products include filtration equipment: soft water systems; pure and ultrapure water systems; tabletop pure and ultrapure water systems; filters; water treatment facilities; water treatment chemicals; ion-exchange resin and replenishment material; and other technologies and services. The company also provides remote monitoring; maintenance planning, scheduled inspections, and supplying of consumables; equipment diagnostics, equipment enhancement, and modification work; and equipment-owned service model services. It provides its products and services to electronics; pharmaceutical and cosmetics; chemicals and machinery; food and beverages; thermal and nuclear power plant; water and sewage treatment plants; healthcare and research institutions; convenience stores and restaurants; and buildings and commercial facilities. The company was formerly known as Japan Organo Co., Ltd. and changed its name to Organo Corporation in 1966. Organo Corporation was incorporated in 1941 and is headquartered in Koto, Japan.
